HC Wainwright & Co. Maintains Buy Rating for MediWound: Here's What You Need To Know
Portfolio Pulse from Benzinga Insights
HC Wainwright & Co. has maintained its Buy rating for MediWound (NASDAQ:MDWD) and increased its price target from $23.00 to $26.00. MediWound's shares are currently trading up 4.97% over the last 24 hours, at $9.50 per share. A move to $26.00 would account for a 173.68% increase from the current share price.
September 21, 2023 | 5:00 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
HC Wainwright & Co. maintains its Buy rating for MediWound and raises its price target, potentially indicating a positive outlook for the company's stock.
The decision by HC Wainwright & Co. to maintain its Buy rating and raise the price target for MediWound indicates a positive outlook for the company's stock. This could potentially lead to an increase in the stock's price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100